Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Rezazadeh, Alireza ^a   Yazdanparast, Razieh ^a   Molaei, Mahsa ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

methionine and choline deficient diet; Mn salen complexes; Nonalcoholic fatty liver; oxidative stress; superoxide dismutase mimetic

Indexed keywords

AMINOTRANSFERASE; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MANGANESE SALEN CHLORIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ETHYLENEDIAMINE DERIVATIVE; EUK-134; METHIONINE; N,N' BIS(SALICYLIDENEAMINO)ETHANE MANGANESE(II); N,N'-BIS(SALICYLIDENEAMINO)ETHANE-MANGANESE(II); ORGANOMETALLIC COMPOUND; SALICYLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEPATITIS; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DIET; DISEASE MODEL; DRUG EFFECT; FATTY LIVER; HUMAN; VITAMIN DEFICIENCY;

RATTUS;

ANIMALS; ASCORBIC ACID; CHOLINE DEFICIENCY; DIET; DISEASE MODELS, ANIMAL; ETHYLENEDIAMINES; FATTY LIVER; HUMANS; LIPID PEROXIDATION; METHIONINE; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; RATS; SALICYLATES;

EID: 84857462541     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-26     Document Type: Article

References (34)

1. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C, Trends Mol Med 2008 14 72 81 10.1016/j.molmed.2007.12.003 18218340
2. From the metabolic syndrome to NAFLD or vice versa? Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G, Dig Liver Dis 2010 42 320 330 10.1016/j.dld.2010.01.016 20207596
3. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Zivkovic AM, German JB, Sanyal A, Am J Clin Nutr 2007 86 285 300 17684197 (Pubitemid 47256910)
4. Nonalcoholic fatty liver disease: A review and update. Lewis JR, Mohanty SR, Dig Dis Sci 2010 55 560 578 10.1007/s10620-009-1081-0 20101463
5. The role of oxidative stress in non-alcoholic steatohepatitis. Koek GH, Liedorp PR, Bast A, Clinica Chimica Acta 2011 412 1297 1305 10.1016/j.cca.2011. 04.013
6. Oxidative stress and metabolic syndrome. Roberts CK, Sindhu K, Life Sci 2009 84 705 712 10.1016/j.lfs.2009.02.026 19281826
7. Teucrium polium in prevention of steatohepatitis in rats. Amini R, Nosrati N, Yazdanparast R, Molaei M, Liver Int 2009 29 1216 1221 10.1111/j.1478-3231.2009.02033.x 19602140
8. Metabolic syndrome and oxidative stress. Ando K, Fujita T, Free Ralic Biol Med 2009 47 213 218 10.1016/j.freeradbiomed.2009.04.030
9. Superoxide dismutase mimetics. Salvemini D, Muscoli C, Riley DP, Cuzzocrea S, Pulm Pharmacol Ther 2002 15 439 447 10.1006/pupt.2002.0374 12406666 (Pubitemid 35333889)
10. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Batini-Haberle I, Rebouças J, Spasojevi I, Antioxid Redox Signal 2010 13 877 918 10.1089/ars.2009.2876 20095865
11. Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. Doctrow SR, Huffman K, Marcus CB, Tocco G, Malfroy E, Adinolfi CA, Kruk H, Baker K, Lazarowych N, Mascarenhas J, Malfroy B, J Med Chem 2002 45 4549 4558 10.1021/jm020207y 12238934
12. New conjugates of superoxide dismutase/catalase mimetics with cyclodestrins. Lanza V, Vecchio G, Journal of inorganic biochemistry 2009 103 381 388 10.1016/j.jinorgbio.2008.11.017 19135258
13. Orally available Mn porphyrins with superoxide dismutase and catalase activities. Rosenthal RA, Huffman KD, Fisette LW, Damphousse CA, Callaway WB, Malfroy B, Doctrow SR, J Biol Inorg Chem 2009 14 979 991 10.1007/s00775-009- 0550-4 19504132
14. EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Rong Y, Doctrow SR, Tocco G, Baudry M, Proc Natl Acad Sci USA 1999 96 9897 9902 10.1073/pnas.96.17.9897 10449791 (Pubitemid 29398829)
15. Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Jung C, Rong Y, Doctrow S, Baudry M, Malfroy B, Xu Z, Neurosci Lett 2001 304 157 160 10.1016/S0304-3940(01)01784-0 11343826 (Pubitemid 32436400)
16. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. Baker K, Marcus CB, Huffman K, Kruk H, Malfroy B, Doctrow SR, J Pharmacol Exp Ther 1998 284 215 221 9435181 (Pubitemid 28109549)
17. Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model. Ustundag B, Bahcecioglu IH, Sahin K, Duzgun S, Koca S, Gulcu F, Hanifi Ozercan I, Dig Dis Sci 2007 52 2006 2014 10.1007/s10620-006-9251-9 17420940 (Pubitemid 47024653)
18. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Hepatology 2005 41 1313 1321 10.1002/hep.20701 15915461 (Pubitemid 40770284)
19. Protein measurement with the Folin phenol reagent. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, JBC 1951 193 265 275
20. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Kakkar R, Mantha S, Radhi J, Prasad K, Kalra J, Clin Sci 1998 94 623 632 9854460 (Pubitemid 28269062)
21. Antioxidant and free radical scavenging potential of Achilleasantolina extracts. Ardestani A, Yazdanparast R, Food Chem 2007 104 21 29 10.1016/j.foodchem.2006.10.066 (Pubitemid 46561097)
22. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Reznick AZ, Packer L, Methods Enzymol 1994 233 357 363 8015470
23. Novel treatment strategies for patients with nonalcoholic fatty liver disease. Lam B, Younossi Z, Clin Invest 2011 1 229 239 10.4155/cli.10.24
24. Non-alcoholic steatohepatitis in a sample of iranian adult population: age is a risk factor. Rogha M, Najafi N, Azari A, Kaji M, Pourmoghaddas Z, Rajabi F, Rezaee M, Int J Prev Med 2011 2 24 27 21448401
25. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Laurent A, Nicco C, Tran Van Nhieu J, Borderie D, Chereau C, Conti F, Jaffray P, Soubrane O, Calmus Y, Weill B, Batteux F, Hepatology 2004 39 1277 1285 10.1002/hep.20177 15122756 (Pubitemid 38569049)
26. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Turner SM, Badger TM, Pitas RE, Maher JJ, J Lipid Res 2006 47 2280 2290 10.1194/jlr.M600198-JLR200 16829692 (Pubitemid 44936138)
27. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Weltman MD, Farrell GC, Liddle C, Gastroenterology 1996 111 1645 1653 10.1016/S0016-5085(96)70028-8 8942745 (Pubitemid 26404230)
28. Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha. Ramirez-Tortosa MC, Ramirez-Tortosa CL, Mesa MD, Granados S, Gil A, Quiles JL, Free Rradic Biol Med 2009 47 924 931 10.1016/j.freeradbiomed.2009.06.015
29. Nasturtium officinale reduces oxidative stress and enhances antioxidant capacity in hypercholesterolaemic rats. Yazdanparast R, Bahramikia S, Ardestani A, Chem Biol Int 2008 172 176 184 10.1016/j.cbi.2008.01.006
30. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Koruk M, Taysi S, Cemil Savas M, Yilmaz O, Akcay F, Karakok M, Ann Clin Lab Sci 2004 34 57 62 15038668 (Pubitemid 38280304)
31. Paraoxonase1 and platelet-activating factor acetylhydrolase activities in patients with low HDL-cholesterol levels with or without primary hypertriglyceridemia. Brites F, Verona J, Schreier LS, Fruchart JC, Castro JR, Wikinski RS, Arch Med Res 2004 35 235 240 10.1016/j.arcmed.2004.02.002 15163466 (Pubitemid 38648994)
32. Friend turns foe: transformation of anti-inflammatory HDL-C to proinflammatory HDL-C during acute-phase response. Bindu GH, Rao VS, Kakkar VV, Cholesterol 2011 2011 7
33. The versatility of HDL-C: a crucial anti-inflammatory regulator. Saemann M, Poglitsch M, Kopecky C, Haidinger M, Horl W, Weichhart T, Eur J Clin Invest 2010 40 1131 1143 10.1111/j.1365-2362.2010.02361.x 20695882
34. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Chiu CJ, Taylor A, Prog Retin Eye Res 2011 30 18 53 10.1016/j.preteyeres.2010. 09.001 20868767